Clinical Pathway for Evaluation and Treatment of Iron Deficiency
and Anemia in Patients with Inflammatory Bowel Disease (IBD)
Universal Screening for Iron Deficiency and Anemia
- CBC, reticulocyte count
- Iron panel
- Serum iron, TIBC, transferrin, transferrin saturation (TSAT)
- Ferritin
- Soluble transferrin receptor (STFR)
- Active IBD q3mos
- Inactive IBD q6mos
| Iron Deficiency in Relation to Disease Activity | |
|---|---|
| Active IBD |
|
| Inactive IBD |
|
Adequate iron stores,
No anemia
No anemia
Adequate iron stores,
Anemia
Anemia
Iron deficiency
with or without anemia
with or without anemia
Inactive IBD
Active IBD
Continue universal screening
Inactive IBD: q6mos
Active IBD: q3mos
Evaluate for other causes of anemia
Assess anemia level
| WHO Anemia Severity Range Hgb (g/dL) | ||||
|---|---|---|---|---|
| Age (yrs) | Mild | Moderate | Severe | |
| < 5 | < 11 | < 10 | < 7 | |
| ≥ 5 | < 11.5 | < 11 | < 8 | |
| 12–14 | < 12 | < 11 | < 8 | |
| ≥ 15 | (F) < 12 | (M) < 13 | < 11 | < 8 |
Mild or
non-anemic
non-anemic
Moderate or severe
IV Iron Rationale
- Decreased intestinal absorption due to mucosal inflammation and increased hepcidin levels.
- Potential exacerbation of bowel inflammation and increased intolerance with enteral.
- Benefits and Limitations of Oral vs. Intravenous Iron
Review hematologic response to iron
Repeat CBC and reticulocyte in 4 wks
Repeat CBC and reticulocyte in 4 wks
Normalization or hgb increase by ≥ 2g/dL from baseline and normalization of iron store
Inadequate hgb or iron store response to iron treatment
- Prevent Recurrent Iron Deficiency and Anemia
- Anemia recurs in > 50% of children with IBD within 10–12 mos
- Recommend q3mo universal screening for 1 yr after correction at minimum
- Rapid recurrent iron deficiency with or without anemia may be indicative of subclinical disease activity
- Administer IV Iron if failed or concern for poor adherence to oral regimen
- Reassess disease activity, blood loss, other causes of anemia
- Consider hematology referral
Evidence
- Utilization of an Electronic Medical Record-integrated Dashboard Improves Identification and Treatment of Anemia and Iron Deficiency in Pediatric Inflammatory Bowel Disease
- Anemia in Children with Inflammatory Bowel Disease: A Position Paper by the IBD Committee of the North American Society of Pediatric Gastroenterology, Hepatology and Nutrition
- European Consensus on the Diagnosis and Management of Iron Deficiency and Anaemia in Inflammatory Bowel Disease
- Assessment of Gaps in Care and the Development of a Care Pathway for Anemia in Patients with Inflammatory Bowel Diseases
- Iron Deficiency across Chronic Inflammatory Conditions: International Expert Opinion on Definition, Diagnosis, and Management
- Haemoglobin Concentrations for the Diagnosis of Anaemia and Assessment of Severity
- Serum Transferrin Receptor and Its Ratio to Serum Ferritin in the Diagnosis of Iron Deficiency
- Soluble Transferrin Receptor and Transferrin Receptor-Ferritin Index in Iron Deficiency Anemia and Anemia in Rheumatoid Arthritis
- Soluble Transferrin Receptor-Ferritin Index in the Evaluation of Anemia in Inflammatory Bowel Disease: a Case-Control Study